This paper reports the finding of a unique isoenzyme of ALP which has not been observed previously on review of the literature. Since this isoenzyme migrates towards the anode and is faster than the isoenzyme described by Fritsche and Adams-Park (1972; 1974) , we have chosen to call it the ultrafast liver isoenzyme of ALP. Previous investigators have identified a regular liver isoenzyme and an abnormally anodally migrating enzyme referred to as preliver or fast liver. In contrast to these ALP isoenzymes, which we have likewise observed, the ultrafast isoenzyme migrates faster towards the anode than the other two liver isoenzymes in the area corresponding to albumin on cellulose acetate electrophoretic media.
Material and methods
Patients' sera were selected on the basis of an elevated ALP and were electrophoresed immediately or stored at -70°C until the day of electrophoresis.
Clinical information was correlated with the laboratory findings.
The isoenzymes of alkaline phosphatase were delineated using the Helena Laboratory alkaline phosphatase isoenzyme procedure, which entailed the use of Titan III-Iso cellulose acetate plates, 60 x 75 mm, Electro HR (barbital) buffer, and alpha naphthol ASMX phosphate reagent, which was subsequently coupled with the diazo compound, Fast Blue RR, yielding sharp blue visible bands. The
Received for publication 17 May 1979 developed plates were then scanned on an Auto Scanner Flur-Vis densitometer.
Identification of individual isoenzyme bands was made utilising reference alkaline phosphatase control sera supplied by the Helena Laboratory consisting of bovine intestinal and liver isoenzymes.
To determine if the ultrafast liver isoenzyme was an artifact of a complex bilirubin and albumin and Fast Blue RR, a number of serum samples with elevated serum bilirubin and alkaline phosphatase levels were electrophoresed and subsequently developed with ASMX (containing alpha naphthol phosphate) and Fast Blue RR or barbital buffer (pH 8-8 with Fast Blue RR only).
Results
We observed a fast liver fraction in conjunction with an ultrafast liver band in three patients with various diseases, including carcinoma of the head of the pancreas with metastasis to the liver (Fig. 2 ), ovarian carcinoma with suspected metastasis to the liver (Fig. 3) , and breast carcinoma metastatic to the liver (Fig. 4) . This unique ultrafast liver isoenzyme has also been observed in conjunction with a regular liver isoenzyme in the absence of the fast liver fraction (Figs 1, 5, 6 Fig. 6 ). We have also observed a fast liver fraction associated with Hodgkin's disease causing a large filling defect of the liver on liverspleen scan (case 8; Fig. 7) . We have also seen this similar isoenzyme pattern in one patient with haemochromatosis (case 9; Fig. 8 ) and renal cell adenocarcinoma (case 10; Fig. 9 ), and in another patient with disseminated coccidioidomycosis (case 11), and adenocarcinoma of lung (case 14; Fig. 10 (Fishman, 1974; Whitby and Moss, 1975) . We therefore have sought another modality to aid in the differential diagnosis of an elevated serum ALP. We chose the Helena Laboratory isoenzyme electrophoresis procedure on cellulose acetate membranes because of the ease of handling, stability of the supporting membrane and media, and the reproducibility of results. All these factors have made this procedure attractive for the laboratory worker in an extremely active clinical laboratory. In contrast, although acrylamide gel electrophoresis is more discriminating because of its molecular sieving action as well as its separation on the basis of charge, this medium requires preparation of individual components and polymerisation steps and in some cases pre-electrophoresis to remove any potential interfering substances that might inhibit enzymatic activity (Gordon, 1971; Emery and Dounce, 1955; Thines-Sempoux, 1973 ).
Previous investigators, using different separating media, have identified the presence of a fast liver band in patients with liver disease (Fritsche and Adams-Park, 1974; Afonja and Baron, 1974) , and this band may represent the slow moving isoenzyme noted in polyacrylamide gel electrophoresis (Fritsche and Adams-Park, 1974; Price and Sammons, 1974) . De Broe et al., l975 found that the high molecular weight alkaline phosphatase with rapid migration on cellulose acetate electrophoresis corresponded to a membrane-vesicle fraction seen with electron microscopy in patients with cholestasis. The unique isoenzyme that we have observed may be a posttranslationally modified enzyme of the liver type associated with a lecithin-liver isoenzyme complex, which induces a change in its electrophoretic mobility, as described by Price and Sammons (1974) . , ! . ' t ' ' > A the ultrafast isoenzyme. Moreover, we are investigating the effect of enzymatic degradation of the new isoenzyme in an attempt to define its reactivity in the absence of potentially critical carbohydrate moieties.
Previous reports have identified three isoenzymes of alkaline phosphatase in patients with cirrhosis (Fishman, 1974) . They include the regular liver, bone, and intestinal isoenzyme. The elevation of the intestinal isoenzyme has been noted by us (Table l) and may be related to anoxic injury to the gastrointestinal tract induced by portal hypertension. The elevated bone fraction has been thought to be secondary to a defect or decreased activity in the 25-hydroxylase enzyme of the liver in cirrhosis, which converts cholecalciferol to its 25-hydroxylated product, which is the precursor to the active The ultrafast liver band has been attributed to an artifact caused by a bilirubin albumin complex and Fast Blue RR utilised in the electrophoretic technique (Hardin et al., 1978) . However, another publication (Tsung, 1978) (Fig. 11) .
In conclusion, the ultrafast alkaline phosphatase isoenzyme appears to be a true isoenzyme and associated most commonly with neoplastic disease of the liver.
In summary, we have described a new isoenzyme of alkaline phosphatase, which surprisingly has not been reported previously. Whether or not this isoenzyme is only demonstrated utilising the alpha naphthol substrate of the Helena Laboratory procedure has not been elucidated to date. Perhaps other substrates such as thymolphthalein phosphate, beta glycerol phosphate, or indoxyl phosphate will likewise react with this enzyme. We hope this paper will encourage other investigators to help to identify and corroborate our findings and attempt to assign this isoenzyme clinical and diagnostic relevancy.
